| 000 | 00902 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250512180957.0 | ||
| 264 | 0 | _c19690801 | |
| 008 | 196908s 0 0 eng d | ||
| 022 | _a0021-9746 | ||
| 024 | 7 |
_a10.1136/jcp.22.3.368-b _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFearnley, G R | |
| 245 | 0 | 0 |
_aPharmacological enhancement of fibrinolysis. _h[electronic resource] |
| 260 |
_bJournal of clinical pathology _cMay 1969 |
||
| 300 |
_a368-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aEthylestrenol _xpharmacology |
| 650 | 0 | 4 |
_aFibrinogen _xanalysis |
| 650 | 0 | 4 |
_aFibrinolysis _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPhenformin _xpharmacology |
| 700 | 1 | _aChakrabarti, R | |
| 773 | 0 |
_tJournal of clinical pathology _gvol. 22 _gno. 3 _gp. 368-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/jcp.22.3.368-b _zAvailable from publisher's website |
| 999 |
_c5785532 _d5785532 |
||